Selatogrel Outcome Study in Suspected Acute Myocardial Infarction

This study is looking for adults aged 18 and over, both men and women, who have recently had a heart attack and meet certain health requirements. Specifically, you would need to have had a confirmed heart attack of a certain type (called Type 1) within the last four weeks. You also need to have other health conditions, such as narrowed blood vessels in your heart, along with at least one additional risk factor like a previous heart attack, diabetes, kidney problems, or circulation issues in your legs.

There are also some reasons why you might not be able to join. For example, if you have a high risk of serious bleeding, have had certain types of strokes recently, have very low levels of certain blood cells, or have serious liver problems, this study might not be right for you. Your doctor would carefully review your full medical history to determine if you are a good fit.

Before you start, you'd also need to be able to successfully practice using the auto-injector with a dummy medicine, to make sure you can administer the treatment correctly if needed.

If you decide to take part, you would be randomly assigned to receive either Selatogrel or a placebo (a dummy medicine with no active ingredients). You would be provided with an auto-injector and trained on how to use it. The idea is that if you experience symptoms that suggest another heart attack, you would give yourself the assigned medicine following the instructions. You would have regular check-ups with the study team to monitor your health and any events that occur. The exact number of visits and the total duration aren't specified here, but clinical trials usually involve ongoing follow-up for a significant period to track long-term effects. You would continue to see your usual doctors as well.